Winton Group’s Gossamer Bio GOSS Stock Holding History

Winton Group’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23,479	Closed	-$367K	–	1453
2019 Q4	$367K	Buy	+23,479	New	+$473K	0.01%	1326

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winton Group's GOSS Position: Q1 2020 in Review

Winton Group sold out of Gossamer Bio (GOSS) in Q1 2020, closing a stake of 23,479 shares — an estimated $367K sold.

Winton Group first reported a position in GOSS in Q4 2019 and held it in 1 quarter. The position peaked at $367K in Q4 2019. 96 funds tracked by Wall St. Rank hold GOSS as of Q1 2020.

Winton Group reported no remaining Gossamer Bio position as of Q1 2020 after selling out during the quarter.
Winton Group sold 23,479 Gossamer Bio shares in Q1 2020, an estimated $367K.
Winton Group first reported a position in Gossamer Bio in Q4 2019 and held it in 1 quarter.
Winton Group's Gossamer Bio position peaked at $367K in Q4 2019.
96 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2020.

Based on Winton Group's 13F filing for Q1 2020, filed 11 May 2020.